Vivo Capital Fund VIII, L.P., 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 311,488 shares at $13.80 ($4.3M) on 2020-04-03, disclosed to the SEC on 2020-04-07.
Open-market sale of $4.3M CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.80 | 36,400 | $502K | 11.7% |
| 2 | $13.80 | 263,600 | $3.6M | 84.5% |
| 3 | $14.20 | 742 | $11K | 0.2% |
| 4 | $14.20 | 5,373 | $76K | 1.8% |
| 5 | $14.20 | 5,373 | $76K | 1.8% |
| Total | $13.81 avg | 311,488 |
| $4.3M |
| 100% |
| Filing → |
| CRNX | BUY | 2018-07-20 | $9.8M | — | Filing → |
| MNLO | BUY | 2018-01-29 | $5.0M | — | Filing → |
| BPMX | BUY | 2017-05-01 | $2.0M | — | Filing → |